Document is current

Any future updates will be listed below

Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways

Crossref DOI link: https://doi.org/10.1038/s41419-025-07495-2

Published Online: 2025-04-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark